Material Safety Data Sheet
Ammonium metavanadate, p.a.
ACC# 00242
Section 1 - Chemical Product and Company Identification |
MSDS Name: Ammonium metavanadate, p.a.
Catalog Numbers:
AC194910000, AC194910500, AC194912500
Synonyms:
Ammonium vanadate; Vanadic acid ammonium salt; Ammonium
trioxovanadate
Company Identification:
Acros Organics N.V.
One Reagent Lane
Fair Lawn, NJ 07410
For information in North America, call: 800-ACROS-01
For emergencies in the US, call CHEMTREC: 800-424-9300
Section 2 - Composition, Information on Ingredients
|
CAS# |
Chemical Name |
Percent |
EINECS/ELINCS |
7803-55-6 | Ammonium metavanadate |
ca.100 | 232-261-3 |
Hazard Symbols: T
Risk Phrases: 25 33 36/37/38
Section 3 - Hazards Identification
|
EMERGENCY OVERVIEW
Appearance: slightly yellow crystalline powder.
Causes digestive and respiratory tract irritation. Causes eye and
skin irritation. May cause blood abnormalities. May cause allergic
skin reaction. Hygroscopic (absorbs moisture from the air).
Danger! May be fatal if inhaled. Harmful if swallowed. May
cause reproductive and fetal effects.
Target Organs: Respiratory system, red blood
cells, nervous system.
Potential Health Effects
Eye:
Contact produces irritation, tearing, and burning pain. May cause
conjunctivitis.
Skin:
Causes skin irritation.
Ingestion:
Harmful if swallowed. Causes gastrointestinal irritation with
nausea, vomiting and diarrhea. Vanadium compounds can cause
polycythemia, followed by red blood cell destruction, anemia, loss
of appetite, pallor, and emaciation. May cause greenish-black tongue
discoloration due to deposition of vanadium salts.
Inhalation:
May be fatal if inhaled. Causes upper respiratory tract irritation.
Causes irritation of the mucous membrane. Inhalation may cause sore
throat, shortness of breath, labored breathing, coughing, and
pulmonary edema.
Chronic:
Repeated exposure may cause sensitization dermatitis. Chronic
exposure may cause a greenish tongue, metallic taste, cough, chronic
bronchitis, and emphysema. Material is a potent enzyme inhibitor.
Effects may be delayed. Laboratory experiments have resulted in
mutagenic effects. May cause adverse reproductive effects. May
produce scattered allergy-like eczematous skin lesions symptomatic of
vanadium toxicity.
Section 4 - First Aid Measures
|
Eyes:
Immediately flush eyes with plenty of water for at least 15 minutes,
occasionally lifting the upper and lower eyelids. Get medical aid.
Skin:
Get medical aid. Immediately flush skin with plenty of water for at
least 15 minutes while removing contaminated clothing and shoes.
Wash clothing before reuse.
Ingestion:
Call a poison control center. If swallowed, do not induce vomiting
unless directed to do so by medical personnel. Never give anything by
mouth to an unconscious person. Get medical aid.
Inhalation:
Get medical aid immediately. Remove from exposure and move to fresh
air immediately. If breathing is difficult, give oxygen. Do NOT use
mouth-to-mouth resuscitation. If breathing has ceased apply
artificial respiration using oxygen and a suitable mechanical device
such as a bag and a mask.
Notes to Physician:
Green coloration of the tongue, resulting from the deposition of
vanadium salts is an indicator of exposure; however, may be absent
even in prolonged exposure.. Treat symptomatically and supportively.
Effects may be delayed.
Section 5 - Fire Fighting Measures
|
General Information:
As in any fire, wear a self-contained breathing apparatus in
pressure-demand, MSHA/NIOSH (approved or equivalent), and full
protective gear. During a fire, irritating and highly toxic gases
may be generated by thermal decomposition or combustion. This
material in sufficient quantity and reduced particle size is capable
of creating a dust explosion.
Extinguishing Media:
Substance is noncombustible; use agent most appropriate to
extinguish surrounding fire.
Flash Point: Not applicable.
Autoignition Temperature: Not applicable.
Explosion Limits, Lower:Not available.
Upper: Not available.
NFPA Rating:
(estimated) Health: 3; Flammability: 0; Instability: 0
Section 6 - Accidental Release Measures
|
General Information: Use proper personal protective equipment as indicated
in Section 8.
Spills/Leaks:
Vacuum or sweep up material and place into a suitable disposal
container. Avoid runoff into storm sewers and ditches which lead to
waterways. Clean up spills immediately, observing precautions in the
Protective Equipment section. Avoid generating dusty conditions. Use
water spray to disperse the gas/vapor. Provide ventilation.
Section 7 - Handling and Storage
|
Handling:
Wash thoroughly after handling. Remove contaminated clothing and
wash before reuse. Minimize dust generation and accumulation. Do not
breathe dust, vapor, mist, or gas. Do not get in eyes, on skin, or
on clothing. Keep container tightly closed. Do not ingest or inhale.
Use only in a chemical fume hood.
Storage:
Keep away from heat, sparks, and flame. Do not store near
combustible materials. Keep container closed when not in use. Store
in a tightly closed container. Store in a cool, dry, well-ventilated
area away from incompatible substances. Store protected from
moisture.
Section 8 - Exposure Controls, Personal Protection
|
Engineering Controls:
Facilities storing or utilizing this material should be equipped
with an eyewash facility and a safety shower. Use only under a
chemical fume hood.
Exposure Limits
Chemical Name |
ACGIH |
NIOSH |
OSHA - Final PELs |
Ammonium metavanadate | none listed |
none listed | none listed |
OSHA Vacated PELs:
Ammonium metavanadate:
No OSHA Vacated PELs are listed for this chemical.
Personal Protective Equipment
Eyes:
Wear appropriate protective eyeglasses or chemical
safety goggles as described by OSHA's eye and face
protection regulations in 29 CFR 1910.133 or European
Standard EN166.
Skin:
Wear appropriate protective gloves to prevent skin
exposure.
Clothing:
Wear appropriate protective clothing to prevent skin
exposure.
Respirators:
A respiratory protection program that meets OSHA's 29
CFR 1910.134 and ANSI Z88.2 requirements or European
Standard EN 149 must be followed whenever workplace
conditions warrant a respirator's use.
Section 9 - Physical and Chemical Properties
|
Physical State: Crystalline powder
Appearance: white - slightly yellow
Odor: Not available.
pH: Not available.
Vapor Pressure: Negligible.
Vapor Density: Not available.
Evaporation Rate:Negligible.
Viscosity: Not available.
Boiling Point: Not available.
Freezing/Melting Point:200 deg C
Decomposition Temperature:200 deg C
Solubility: 6.2 g/l (15 c)
Specific Gravity/Density:2.3260g/cm3
Molecular Formula:H4NO3V
Molecular Weight:116.98
Section 10 - Stability and Reactivity
|
Chemical Stability:
Stable under normal temperatures and pressures.
Conditions to Avoid:
Incompatible materials, dust generation, exposure to moist air or
water, excess light.
Incompatibilities with Other Materials:
Strong oxidizing agents, strong acids, moisture.
Hazardous Decomposition Products:
Oxides of nitrogen, irritating and toxic fumes and gases, vanadium
oxide (VOx) gases, ammonia.
Hazardous Polymerization: Will not occur.
Section 11 - Toxicological Information
|
RTECS#:
CAS# 7803-55-6: YW0875000
LD50/LC50:
CAS# 7803-55-6:
Inhalation, rat: LC50 = 7800 ug/m3/4H;
Oral,
mouse: LD50 = 25 mg/kg;
Oral, rat: LD50 = 58100 ug/kg;
Skin,
rat: LD50 = 2102 mg/kg;
Carcinogenicity:
CAS# 7803-55-6:
Not listed by ACGIH, IARC, NIOSH, NTP, or OSHA.
Epidemiology:
No information available.
Teratogenicity:
Intraperitoneal, hamster: TDLo = 22500 ug/kg (female 5-10 day(s)
after conception) Effects on Newborn - sex ratio.; Intraperitoneal,
hamster: TDLo = 2820 ug/kg (female 5-10 day(s) after conception)
Specific Developmental Abnormalities - musculoskeletal system.
Reproductive Effects:
Intraperitoneal, hamster: TDLo = 11280 ug/kg (female 5-10 day(s)
after conception) Fertility - post-implantation mortality (e.g. dead
and/or resorbed implants per total number of implants) and Effects on
Embryo or Fetus - fetal death.;
Neurotoxicity:
No information available.
Mutagenicity:
Micronucleus Test: Human, Lymphocyte = 10 umol/L; DNA Damage: Human,
Lymphocyte = 200 umol/L; Sister Chromatid Exchange: Human,
Lymphocyte = 40 umol/L; Sex Chromosome Loss and Nondisjunction:
Human, Lymphocyte = 40 umol/L.
Other Studies:
No data available.
Section 12 - Ecological Information
|
Ecotoxicity:
Fish: Goldfish: LC50 = 1.5 - 3.8; 144 Hr; Unspecified
Fish:
Goldfish: LC50 = 1.5 - 3.8 mg/L; 144 Hr; unspecified
Section 13 - Disposal Considerations
|
Chemical waste generators must determine whether a discarded chemical is classified
as a hazardous waste.
US EPA guidelines for the classification determination are listed in 40 CFR Parts 261.3.
Additionally, waste generators must consult state and local hazardous waste regulations to
ensure complete and accurate classification.
RCRA P-Series: CAS# 7803-55-6: waste number
P119.
RCRA U-Series: None listed.
Section 14 - Transport Information
|
|
US DOT |
IATA |
RID/ADR |
IMO |
Canada TDG |
Shipping Name: |
AMMONIUM METAVANADATE |
|
|
|
No information available. |
Hazard Class: |
6.1 |
|
|
|
|
UN Number: |
UN2859 |
|
|
|
|
Packing Group: |
II |
|
|
|
|
Section 15 - Regulatory Information
|
US FEDERAL
TSCA
CAS# 7803-55-6 is listed on the TSCA inventory.
Health & Safety Reporting List
None of the chemicals are on the Health & Safety Reporting List.
Chemical Test Rules
None of the chemicals in this product are under a Chemical Test Rule.
Section 12b
None of the chemicals are listed under TSCA Section 12b.
TSCA Significant New Use Rule
None of the chemicals in this material have a SNUR under TSCA.
SARA
CERCLA Hazardous Substances and corresponding RQs
CAS# 7803-55-6: 1000 lb final RQ; 454 kg final RQ
SARA Section 302 Extremely Hazardous Substances
None of the chemicals in this product have a TPQ.
SARA Codes
CAS # 7803-55-6: acute.
Section 313
No chemicals are reportable under Section 313.
Clean Air Act:
This material does not contain any hazardous air pollutants.
This material does not contain any Class 1 Ozone depletors.
This material does not contain any Class 2 Ozone depletors.
Clean Water Act:
None of the chemicals in this product are listed as Hazardous
Substances under the CWA.
None of the chemicals in this product are listed as Priority
Pollutants under the CWA.
None of the chemicals in this product are listed as Toxic Pollutants
under the CWA.
OSHA:
None of the chemicals in this product are considered highly hazardous
by OSHA.
STATE
CAS# 7803-55-6 can be found on the following state right to know
lists: New Jersey, Pennsylvania, Massachusetts.
California No Significant Risk Level:
None of the chemicals in this product are listed.
European/International Regulations
European Labeling in Accordance with EC Directives
Hazard Symbols:
T
Risk Phrases:
R 25 Toxic if swallowed.
R 33 Danger of cumulative effects.
R 36/37/38 Irritating to eyes, respiratory system
and skin.
Safety Phrases:
S 22 Do not breathe dust.
S 24/25 Avoid contact with skin and eyes.
S 45 In case of accident or if you feel unwell, seek
medical advice immediately (show the label where
possible).
WGK (Water Danger/Protection)
CAS# 7803-55-6: No information available.
Canada - DSL/NDSL
CAS# 7803-55-6 is listed on Canada's DSL List.
Canada - WHMIS
This product has a WHMIS classification of D1A, D2B.
Canadian Ingredient Disclosure List
CAS# 7803-55-6 is listed on the Canadian Ingredient Disclosure List.
Exposure Limits
CAS# 7803-55-6: OEL-AUSTRALIA:TWA 0.05 mg(V2O5)/m3 JANUARY 1993 OE
L-BELGIUM:TWA 0.05 mg(V2O5)/m3 JANUARY 1993 OEL-DENMARK:TWA 0.03 mg(
V2O5)/m3 JANUARY 1993 OEL-FINLAND:TWA 0.5 mg(V2O5)/m3 JANUARY 1993
OEL-FRANCE:TWA 0.05 mg(V2O5)/m3 JANUARY 1993 OEL-GERMANY:TWA 0.05 m
g(V2O5)/m3 JANUARY 1993 OEL-HUNGARY:TWA 0.05 mg(V2O5)/m3;STEL 0.1 mg
(V205)/m3 JANUARY 1993 OEL-JAPAN:TWA 0.5 mg(V2O5)/m3 JANUARY 1993
OEL-THE NETHERLANDS:TWA 0.5 mg(V2O5)/m3 JANUARY 1993 OEL-THE PHILIPP
INES:TWA 0.25 mg(V205)/m3 JANUARY 1993 OEL-POLAND:TWA 0.5 mg(V2O5)/m
3 JANUARY 1993 OEL-SWEDEN:STEL 0.05 mg(V2O5)/m3 JANUARY 1993 OEL-S
WEDEN:TWA 0.2 mg(V2O5)/m3 (dust) OEL-SWITZERLAND:TWA 0.05 mg(V2O5)/m
3;STEL 0.25 mg(V2O5)/m3 OEL-TURKEY:TWA 0.5 mg(V2O5)/m3 JANUARY 1993
OEL-UNITED KINGDOM:TWA 0.05 mg(V2O5)/m3 (dust) OEL-UNITED KINGDOM:T
WA 0.5 mg(V2O5)/m3 JANUARY 1993
Section 16 - Additional Information
|
MSDS Creation Date: 5/04/1999
Revision #2 Date: 12/03/2002
The information above is believed to be accurate and represents the best
information currently available to us. However, we make no warranty of
merchantability or any other warranty, express or implied, with respect to
such information, and we assume no liability resulting from its use. Users
should make their own investigations to determine the suitability of the
information for their particular purposes. In no event shall Fisher be liable
for any claims, losses, or damages of any third party or for lost profits
or any special, indirect, incidental, consequential or exemplary
damages, howsoever arising, even if Fisher has been advised of
the possibility of such damages.